| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 10/23/2008 | US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use |
| 10/23/2008 | US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents |
| 10/23/2008 | US20080261824 Identifies novel set of genes specifically expressed in chemosensory or more specifically taste cells, e.g., mouse circumvallate taste cells, and likely taste cells derived from other mammals such as humans and non-human primates; "taste-specific" genes; identifying compounds useful as therapeutics |
| 10/23/2008 | US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins |
| 10/23/2008 | US20080261310 Propagating desert plants in nutrient broth; micropropagation and tissue culture; tissue engineering |
| 10/23/2008 | US20080261309 In vitro multiplication of hoodia plants |
| 10/23/2008 | US20080261308 Using dehydrated animal cell components as part of nutrient broth for propagation of cells/tissues; pelletization |
| 10/23/2008 | US20080261307 Method of isolating and proliferating autologous antigen-specific CD8+ T Cell using anti-4-1BB antibodies |
| 10/23/2008 | US20080261306 Propagating cells on solid support; tissue engineering and repair; regenerative medicine |
| 10/23/2008 | US20080261305 TGF-beta-MEDIATED OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS |
| 10/23/2008 | US20080261304 Interfering RNA with cholesterol moieties linked |
| 10/23/2008 | US20080261303 Method and medicament for inhibiting the expression of a given gene |
| 10/23/2008 | US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease |
| 10/23/2008 | US20080261301 Mammalian cell demonstrating GDP-mannose 4,6-dehydratase (GMD) suppression and which expresses immunoglobulin associated with antibody-dependent cellular cytotoxicity; targeted treatment of tumors |
| 10/23/2008 | US20080261274 Restoration of Cholesterol Independence and Its Use as a Selectable Marker in Ns0 Cell Culture |
| 10/23/2008 | US20080261271 Expression of hiv polypeptides and production of virus-like particles |
| 10/23/2008 | US20080261270 Expression vector comprising nucleotide sequences estrogen receptor protein for use in inhibition of heregulin binding and treatment of breast and prostate cancers |
| 10/23/2008 | US20080261259 Nutrient broth for propagation and maintanence of animal cells for use in treatment of baldness |
| 10/23/2008 | US20080261257 Fluorescent Proteins and Related Methods and Compounds |
| 10/23/2008 | US20080261252 Soluble Interleukin-1 Receptor Accessory Molecule |
| 10/23/2008 | US20080261251 Monoclonal Antibodies, Hybridomas, Improved Method for Determining the Protein Ptx3 and Kit for Said Determination |
| 10/23/2008 | US20080261245 Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 10/23/2008 | US20080261244 Compositions And Methods For Treating And Diagnosing Pancreatic Cancer |
| 10/23/2008 | US20080261241 Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins |
| 10/23/2008 | US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer |
| 10/23/2008 | US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor |
| 10/23/2008 | US20080261201 Methods and compounds to alter virus infection |
| 10/23/2008 | US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
| 10/23/2008 | US20080260932 Corn Plant and Seed Corresponding to Transgenic Event MON89034 and Methods For Detection and Use Thereof |
| 10/23/2008 | US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues |
| 10/23/2008 | US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery |
| 10/23/2008 | US20080260800 Potentiation with such as small intestinal submucosal (SIS) tissue; harnessing inflammatory provoking activity; prostate glands |
| 10/23/2008 | US20080260798 Utilizing biocompatible, three dimensional cell growth promoting device containing alternating layers of A and S strips; providing preferential cellular attachment to active A strips rather than spacer S strips |
| 10/23/2008 | US20080260793 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof |
| 10/23/2008 | US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect |
| 10/23/2008 | US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins |
| 10/23/2008 | US20080260759 Novel Mite Allergen |
| 10/23/2008 | US20080260758 Cell which expresses granulocyte colony stimulating factor and is deficient in major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which stimulates immune response to cancer |
| 10/23/2008 | US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life |
| 10/23/2008 | US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia |
| 10/23/2008 | US20080260754 Prevent transplant rejection; autoimmune diseases |
| 10/23/2008 | US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease |
| 10/23/2008 | US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans |
| 10/23/2008 | US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders |
| 10/23/2008 | US20080260744 Using neuronal membrane protein receptor as screening tool in identifying modulators for treatment of brain disorders |
| 10/23/2008 | US20080260743 Means and Methods for Detecting Methylated Dna |
| 10/23/2008 | US20080260741 Preventive and/or Therapeutic Agent for Cancer |
| 10/23/2008 | US20080260740 Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer |
| 10/23/2008 | US20080260739 Use of Anti-Mortalin 2 Antibody and Functional Nucleic Acid for Cancer Therapies |
| 10/23/2008 | US20080260738 Single chain fc, methods of making and methods of treatment |
| 10/23/2008 | US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy |
| 10/23/2008 | US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders |
| 10/23/2008 | US20080260722 Nutrient broth comprising neurotrophins for use in propgation of nervous system tissues; tissue engineering and repair; regenerative medicine |
| 10/23/2008 | US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes |
| 10/23/2008 | US20080260713 Neukinase, A Downstream protein of neuregulin |
| 10/23/2008 | US20080260707 Isolated homozygous stem cells, differentiated cells derived therefrom and materials and methods for making and using same |
| 10/23/2008 | US20080260706 Transient Transfection with RNA |
| 10/23/2008 | US20080260705 Bioassay comprising monolayer of co-cultured cardiac myocytes and skeletal muscle myoblasts for use as models in identifying modulators of erratic heart beating; treating myocardial disorders |
| 10/23/2008 | US20080260702 Using vector comprising nucleotide sequences coding neublastin as therapeutic treatment for vision defects |
| 10/23/2008 | US20080260701 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy |
| 10/23/2008 | US20080260700 Immortalized pancreatic duct cell for use in treatment of pancreatic disorders and insulin sensitivity; tissue engineering and repair; regenerative medicine |
| 10/23/2008 | US20080260694 Progenitor cell culture for use tissue engineering, tissue repair and regenerative medicine |
| 10/23/2008 | US20080260693 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv) |
| 10/23/2008 | US20080260681 Using poloxamer; therapy for cardiovascular disorders, muscular dystrophy, apoptosis and antiischemic agents |
| 10/23/2008 | US20080260646 Imaging Reporters of Transgene Expression |
| 10/23/2008 | US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease |
| 10/23/2008 | US20080260635 Mediation of cytotoxicity of tumor cells; using cancer disease modifying antibodies and drugs; initiating cytotoxic response; binding analysis |
| 10/23/2008 | CA2683960A1 Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal trna/synthetase pairs |
| 10/23/2008 | CA2683454A1 Tem8 peptides and vaccines comprising the same |
| 10/23/2008 | CA2664844A1 Chemorepulsion of cells |
| 10/23/2008 | CA2663523A1 Novel gene disruptions, compositions and methods relating thereto |
| 10/22/2008 | EP1983057A2 Improved AAV vectors for gene therapy |
| 10/22/2008 | EP1983056A1 Method for transforming monocotyledons |
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1983053A2 Cell distribution control for cells within bioartifical organs |
| 10/22/2008 | EP1983052A2 Methods of cloning and producing fragment chains with readable information content |
| 10/22/2008 | EP1983044A2 Animal cell culture media comprising plant-derived nutrients |
| 10/22/2008 | EP1983043A1 Systems and methods for screening pharmaceutical chemicals |
| 10/22/2008 | EP1983042A1 Method for purifying cardiac myocyte and presumptive cardiac myocyte derived from stem cell and fetus |
| 10/22/2008 | EP1983001A2 Antibodies to mammalian Langerhans cell antigen and their uses |
| 10/22/2008 | EP1982990A1 Cytokine receptor common gamma chain like |
| 10/22/2008 | EP1982735A1 Electroprocessed collagen |
| 10/22/2008 | EP1982732A2 Factor VII or VIIA-like molecules |
| 10/22/2008 | EP1982185A2 Antigen-binding proteins targeting s. aureus orf0657n |
| 10/22/2008 | EP1981989A2 Solid-fluid composition |
| 10/22/2008 | EP1981986A2 Cryoprotective compositions and methods of using same |
| 10/22/2008 | EP1981971A2 Adult stem cell-derived connective tissue progenitors for tissue engineering |
| 10/22/2008 | EP1981970A2 Human embryonic stem cell-derived connective tissue progenitors for tissue engineering |
| 10/22/2008 | EP1981969A1 Gitr antibodies for the treatment of cancer |
| 10/22/2008 | EP1981968A2 Non-human primate embryonic stem and germ cells: methods of use and methods of making same |
| 10/22/2008 | EP1981967A1 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 10/22/2008 | EP1981966A1 Use of human hepatocytes for determining liver function and liver regeneration |
| 10/22/2008 | EP1981965A1 Process and culturing unit for culturing biological cells |
| 10/22/2008 | EP1981911A2 Synergistic compositions for treating hiv |
| 10/22/2008 | EP1794307A4 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
| 10/22/2008 | EP1427322B1 Soft and calcified tissue implants |